Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD.
To assess the clinical impact of noninvasive mechanical ventilation (NIMV) on stable hypercapnic chronic obstructive pulmonary disease, changes in exercise capacity, dyspnoea and simple physiological parameters were evaluated. The time course of these effects during treatment and recovery was also assessed. Patients were randomly allocated to NIMV (n=27) or sham-NIMV (n=15), applied 3 h.day-1, 5 days a week, for 3 weeks. A 6-min walking distance (6MWD), arterial blood gases, spirometry, pattern of breathing, mouth occlusion pressure (P0.1), and respiratory system impedance (P0.1/tidal volume (VT)/inspiratory time (tI)) were measured weekly during treatment and 2 weekly during follow-up. Transition dyspnoea index (TDI) was also measured. During NIMV, carbon dioxide arterial tension decreased progressively, concomitantly with a slow deep pattern of breathing, a proportional increase in the forced expiratory volume in one second (FEV1), the forced vital capacity and significant reductions of P0.1 and P0.1/VT/tI. The 6MWD improved by a mean of 76 m after NIMV, and by 73 m and 61 m 1 and 2 weeks, respectively, after treatment. Dyspnoea improved with a mean TDI of three points. Changes in 6MWD were highly related to TDI and to a lesser extent to changes in FEV1 (r=0.60). The current authors conclude that noninvasive mechanical ventilation has significant and sustained clinical impact in stable hypercapnic chronic obstructive pulmonary disease.
Díaz
O
O
Dept of Respiratory Diseases, Universidad Católica de Chile, Marcoleta 345, Piso 4. Santiago, Chile. diazp@rdc.cl
Bégin
P
P
Andresen
M
M
Prieto
M E
ME
Castillo
C
C
Jorquera
J
J
Lisboa
C
C
D000368:Aged; D000704:Analysis of Variance; D001784:Blood Gas Analysis; D002245:Carbon Dioxide / Q000097:blood; D016009:Chi-Square Distribution; D004417:Dyspnea / Q000175:diagnosis / Q000628:therapy*; D017079:Exercise Tolerance / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006935:Hypercapnia / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011336:Probability; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000628:therapy*; D012121:Respiration, Artificial / Q000379:methods*; D012129:Respiratory Function Tests; D015656:Respiratory Mechanics / Q000502:physiology; D018570:Risk Assessment; D012720:Severity of Illness Index; D016037:Single-Blind Method; D013147:Spirometry; D016896:Treatment Outcome
D002245:Carbon Dioxide